These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 17242369)

  • 1. Stimulation of endogenous neurogenesis by anti-EFRH immunization in a transgenic mouse model of Alzheimer's disease.
    Becker M; Lavie V; Solomon B
    Proc Natl Acad Sci U S A; 2007 Jan; 104(5):1691-6. PubMed ID: 17242369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic strategies for prevention and treatment of Alzheimer's disease.
    Solomon B
    DNA Cell Biol; 2001 Nov; 20(11):697-703. PubMed ID: 11788047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials.
    Lavie V; Becker M; Cohen-Kupiec R; Yacoby I; Koppel R; Wedenig M; Hutter-Paier B; Solomon B
    J Mol Neurosci; 2004; 24(1):105-13. PubMed ID: 15314258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of beta-amyloid plaques in brain of transgenic mouse model of Alzheimer's disease by EFRH-phage immunization.
    Frenkel D; Dewachter I; Van Leuven F; Solomon B
    Vaccine; 2003 Mar; 21(11-12):1060-5. PubMed ID: 12559780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active immunization against Alzheimer's beta-amyloid peptide using phage display technology.
    Solomon B
    Vaccine; 2007 Apr; 25(16):3053-6. PubMed ID: 17287054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peripherally administered sera antibodies recognizing amyloid-β oligomers mitigate Alzheimer's disease-like pathology and cognitive decline in aged 3× Tg-AD mice.
    Wang HC; Yu YZ; Liu S; Zhao M; Xu Q
    Vaccine; 2016 Apr; 34(15):1758-66. PubMed ID: 26945100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Filamentous bacteriophage as a novel therapeutic tool for Alzheimer's disease treatment.
    Solomon B
    J Alzheimers Dis; 2008 Oct; 15(2):193-8. PubMed ID: 18953108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunization against Alzheimer's beta -amyloid plaques via EFRH phage administration.
    Frenkel D; Katz O; Solomon B
    Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11455-9. PubMed ID: 11027345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
    Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and immunotherapy.
    Solomon B
    Curr Alzheimer Res; 2004 Aug; 1(3):149-63. PubMed ID: 15975063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allopregnanolone enhances the neurogenesis of midbrain dopaminergic neurons in APPswe/PSEN1 mice.
    Zhang P; Xie MQ; Ding YQ; Liao M; Qi SS; Chen SX; Gu QQ; Zhou P; Sun CY
    Neuroscience; 2015 Apr; 290():214-26. PubMed ID: 25637494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of anti-beta-amyloid antibodies via phage display technology.
    Frenkel D; Dori M; Solomon B
    Vaccine; 2004 Jun; 22(19):2505-8. PubMed ID: 15193416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
    Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
    J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal Stem Cells Increase Hippocampal Neurogenesis and Neuronal Differentiation by Enhancing the Wnt Signaling Pathway in an Alzheimer's Disease Model.
    Oh SH; Kim HN; Park HJ; Shin JY; Lee PH
    Cell Transplant; 2015; 24(6):1097-109. PubMed ID: 24612635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards Alzheimer's beta-amyloid vaccination.
    Frenkel D; Solomon B
    Biologicals; 2001; 29(3-4):243-7. PubMed ID: 11851323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hippocampal neurogenesis in the APP/PS1/nestin-GFP triple transgenic mouse model of Alzheimer's disease.
    Zeng Q; Zheng M; Zhang T; He G
    Neuroscience; 2016 Feb; 314():64-74. PubMed ID: 26639620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors.
    Giuliani D; Neri L; Canalini F; Calevro A; Ottani A; Vandini E; Sena P; Zaffe D; Guarini S
    Mol Cell Neurosci; 2015 Jul; 67():13-21. PubMed ID: 26003413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
    Kazim SF; Blanchard J; Dai CL; Tung YC; LaFerla FM; Iqbal IG; Iqbal K
    Neurobiol Dis; 2014 Nov; 71():110-30. PubMed ID: 25046994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.